Franklin Resources Inc Ptc Therapeutics, Inc. Transaction History

Franklin Resources Inc

$330 Billion
Q1 2025

A detailed history of Franklin Resources Inc transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 1,273,008 shares of PTCT stock, worth $64.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,273,008

Previous 1,278,188 0.41%

Holding current value

$64.5 Million

Previous $57.7 Million 12.44%

% of portfolio

0.02%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$41.81 - $57.17 $216,575 - $296,140	-5,180 Reduced 0.41%	1,273,008 $64.9 Million
Q4 2024 Feb 12, 2025	SELL	$34.99 - $52.07 $4.58 Million - $6.81 Million	-130,826 Reduced 9.28%	1,278,188 $57.7 Million
Q3 2024 Nov 12, 2024	SELL	$30.39 - $37.66 $1.86 Million - $2.31 Million	-61,336 Reduced 4.17%	1,409,014 $52.3 Million
Q2 2024 Aug 14, 2024	SELL	$24.69 - $40.12 $274,997 - $446,856	-11,138 Reduced 0.75%	1,470,350 $45 Million
Q1 2024 May 13, 2024	BUY	$24.15 - $31.95 $1.33 Million - $1.76 Million	55,110 Added 3.86%	1,481,488 $43.1 Million
Q4 2023 Feb 09, 2024	SELL	$18.07 - $29.37 $11.4 Million - $18.5 Million	-630,855 Reduced 30.67%	1,426,378 $39.3 Million
Q3 2023 Nov 13, 2023	SELL	$22.41 - $41.99 $28.1 Million - $52.7 Million	-1,254,671 Reduced 37.88%	2,057,233 $46.1 Million
Q2 2023 Aug 11, 2023	SELL	$40.4 - $59.1 $5.41 Million - $7.91 Million	-133,894 Reduced 3.89%	3,311,904 $135 Million
Q1 2023 May 12, 2023	SELL	$38.16 - $48.86 $1.67 Million - $2.14 Million	-43,889 Reduced 1.26%	3,445,798 $167 Million
Q4 2022 Feb 10, 2023	SELL	$33.53 - $54.79 $32.8 Million - $53.6 Million	-979,088 Reduced 21.91%	3,489,687 $133 Million
Q3 2022 Nov 14, 2022	SELL	$41.85 - $53.85 $18.5 Million - $23.9 Million	-443,035 Reduced 9.02%	4,468,775 $224 Million
Q2 2022 Aug 11, 2022	SELL	$25.6 - $45.23 $6,502 - $11,488	-254 Reduced 0.01%	4,911,810 $197 Million
Q1 2022 May 13, 2022	BUY	$33.33 - $44.6 $1.03 Million - $1.38 Million	30,850 Added 0.63%	4,912,064 $183 Million
Q4 2021 Feb 11, 2022	BUY	$35.36 - $41.86 $2.41 Million - $2.85 Million	68,157 Added 1.42%	4,881,214 $194 Million
Q3 2021 Nov 12, 2021	SELL	$37.01 - $44.74 $36.2 Million - $43.7 Million	-976,937 Reduced 16.87%	4,813,057 $179 Million
Q2 2021 Aug 13, 2021	BUY	$37.95 - $49.37 $11.8 Million - $15.3 Million	310,792 Added 5.67%	5,789,994 $245 Million
Q1 2021 May 13, 2021	SELL	$46.8 - $68.92 $4.54 Million - $6.68 Million	-96,981 Reduced 1.74%	5,479,202 $259 Million
Q4 2020 Feb 10, 2021	BUY	$47.96 - $67.64 $188,626 - $266,028	3,933 Added 0.07%	5,576,183 $340 Million
Q3 2020 Nov 12, 2020	BUY	$45.41 - $57.07 $7.3 Million - $9.17 Million	160,677 Added 2.97%	5,572,250 $261 Million
Q2 2020 Aug 13, 2020	SELL	$42.56 - $54.98 $4.64 Million - $5.99 Million	-109,009 Reduced 1.97%	5,411,573 $257 Million
Q1 2020 May 13, 2020	BUY	$32.37 - $59.36 $1.63 Million - $2.98 Million	50,274 Added 0.92%	5,520,582 $246 Million
Q4 2019 Feb 12, 2020	BUY	$32.22 - $50.07 $1.34 Million - $2.09 Million	41,659 Added 0.77%	5,470,308 $263 Million
Q3 2019 Nov 14, 2019	BUY	$33.82 - $48.17 $42 Million - $59.8 Million	1,240,509 Added 29.62%	5,428,649 $184 Million
Q2 2019 Aug 14, 2019	BUY	$35.42 - $45.0 $15.7 Million - $20 Million	443,764 Added 11.85%	4,188,140 $188 Million
Q1 2019 May 14, 2019	BUY	$28.09 - $39.49 $14.9 Million - $20.9 Million	530,083 Added 16.49%	3,744,376 $141 Million
Q4 2018 Feb 12, 2019	BUY	$29.83 - $46.51 $17.6 Million - $27.4 Million	588,659 Added 22.42%	3,214,293 $110 Million
Q3 2018 Nov 13, 2018	BUY	$33.9 - $47.77 $89 Million - $125 Million	2,625,634 New	2,625,634 $123 Million

Others Institutions Holding PTCT

# of Institutions

284

Shares Held

78.5M

Call Options Held

223K

Put Options Held

156K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.63B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Ptc Therapeutics, Inc. Transaction History